Abstract: A company may implement automated workflows for convenience of users or to reduce support costs. For example, allowing a user to change an address using an automated workflow may be faster or less expensive than with a human agent. In some instances, a first communications session may be started between a first user and a second user. During the first communications session, one or more communications may be processed to select an intent of the first user and a value of an information item communicated by the first user. An automated workflow may be selected to continue assisting the first user, and the first user may be transferred to a second communications session with the automated workflow. The automated workflow may be initialized with the value of the information item that was provided during the first communications session so that the first user does not need to repeat information.

Abstract: Disclosed are compounds, compositions, and methods for treating an infection by an enveloped virus in a patient in need thereof. The disclosed compounds may be derived from prazole compounds and may inhibit or block the release of an enveloped virus from an infected cell. As such, the disclosed methods may include methods of treating a viral infection by administering the disclosed compounds or pharmaceutical compositions comprising the disclosed compounds.

Abstract: Disclosed are methods and compositions for treating an infection by an enveloped virus in a patient in need thereof. The methods include administering to the patient a compound that inhibits or blocks release of the enveloped virus from an infected cell. As such, the disclosed methods include methods of inhibiting or blocking release of an enveloped virus from a cell. The disclosed methods may include administering to the patient a prazole-type compound having a substituted (pyridin-2-yl)methylsulfinyl-benzimidazole core.

Abstract: A compound having an antiviral activity for inhibiting release of an enveloped virus from a cell is disclosed, including methods of inhibiting release of an enveloped virus from a cell. The antiviral activity of the compound includes inhibiting formation of an associative complex or disrupting formation of an associative complex. The associative complex comprises an L-domain motif of the enveloped virus and at least one cellular polypeptide, or fragment thereof, capable of binding the L-domain motif of the enveloped virus.

Abstract: Disclosed are methods and compositions for treating an infection by an enveloped virus in a patient in need thereof. The methods include administering to the patient a compound that inhibits or blocks release of the enveloped virus from an infected cell. As such, the disclosed methods include methods of inhibiting or blocking release of an enveloped virus from a cell. The disclosed methods may include administering to the patient a prazole-type compound having a substituted (pyridin-2-yl)methylsulfinyl-benzimidazole core.

Abstract: A compound having an antiviral activity for inhibiting release of an enveloped virus from a cell is disclosed, including methods of inhibiting release of an enveloped virus from a cell. The antiviral activity of the compound includes inhibiting formation of an associative complex or disrupting formation of an associative complex. The associative complex comprises an L-domain motif of the enveloped virus and at least one cellular polypeptide, or fragment thereof, capable of binding the L-domain motif of the enveloped virus.

Abstract: A compound having an antiviral activity for inhibiting release of an enveloped virus from a cell is disclosed, including methods of inhibiting release of an enveloped virus from a cell. The antiviral activity of the compound includes inhibiting formation of an associative complex or disrupting formation of an associative complex. The associative complex comprises an L-domain motif of the enveloped virus and at least one cellular polypeptide, or fragment thereof, capable of binding the L-domain motif of the enveloped virus.

Abstract: A compound having an antiviral activity for inhibiting release of an enveloped virus from a cell is disclosed, including methods of inhibiting release of an enveloped virus from a cell. The antiviral activity of the compound includes inhibiting formation of an associative complex or disrupting formation of an associative complex. The associative complex comprises an L-domain motif of the enveloped virus and at least one cellular polypeptide, or fragment thereof, capable of binding the L-domain motif of the enveloped virus.

Abstract: A compound having an antiviral activity for inhibiting release of an enveloped virus from a cell is disclosed, including methods of inhibiting release of an enveloped virus from a cell. The antiviral activity of the compound includes inhibiting formation of an associative complex or disrupting formation of an associative complex. The associative complex comprises an L-domain motif of the enveloped virus and at least one cellular polypeptide, or fragment thereof, capable of binding the L-domain motif of the enveloped virus.

Abstract: A compound having an antiviral activity for inhibiting release of an enveloped virus from a cell is disclosed, including methods of inhibiting release of an enveloped virus from a cell. The antiviral activity of the compound includes inhibiting formation of an associative complex or disrupting formation of an associative complex. The associative complex comprises an L-domain motif of the enveloped virus and at least one cellular polypeptide, or fragment thereof, capable of binding the L-domain motif of the enveloped virus.

Abstract: A compound having an antiviral activity for inhibiting release of an enveloped virus from a cell is disclosed, including methods of inhibiting release of an enveloped virus from a cell. The antiviral activity of the compound includes inhibiting formation of an associative complex or disrupting formation of an associative complex. The associative complex comprises an L-domain motif of the enveloped virus and at least one cellular polypeptide, or fragment thereof, capable of binding the L-domain motif of the enveloped virus.

Abstract: A self-contained business transaction capsule to conduct a wireless transaction includes data regarding the wireless transaction. Transaction logic is provided to complete the wireless transaction. The self-contained business transaction capsule is adapted to be broadcasted to and stored on a portable electronic device.

Abstract: A method of executing programmable instructions includes receiving at a device a mobile agent from a mobile agent dispatching device. The mobile agent includes a state of a virtual machine. The method also includes executing at the device one or more instructions identified by the mobile agent, thereby changing the state of the virtual machine.

Abstract: A method for executing operations on a device includes executing one or more bytecode language instructions associated with a mobile agent. The mobile agent includes a state of a virtual machine and the bytecode language includes instructions such WARP, MESG; ESEL, ALERT, BROWSE, CAPS, SLEEP, and GPS.

Abstract: The invention is achieved by using single or multiple laser sources (laser diodes) in a configuration such that when it is coupled with a dichroic substrate the laser sources outputs are coupled to produce a single desired output. The dismounted soldiers in the Department of Defense are overloaded with equipment they must carry into the combat environment. Due to many advancements in laser technology, laser devices have been produced to enhance the soldiers' war fighting capability or to provide them with realistic training aids. Unfortunately, these devices have separate housings, controls, power supplies, controls, laser sources and optics which leads to an undesired weight, space and power claims. The present invention consolidates multiple laser functions for the dismounted soldier into a single package with shared power supplies, optics and laser sources thus, minimizing the claim on weight, space, and power.

Abstract: An improvement in a single-shot laser rangefinder having a photo-detector for detecting return laser pulse signals, a signal amplifier for amplifying the return laser pulse signals, and a range processor for determining the range of a reflecting object from the round trip time of flight of the return laser pulse signals. The difference in time at which the strongest laser pulse signal crosses the threshold for detection and the weakest laser pulse signal crosses the threshold for detection causes a timing error in the measured range.